The nine registered records
Each record below is a registration and nothing more. It is anchored by its identifier, never by its title, and the pack reports no result from any of them.
- A completed phase 3 record registered in premenopausal women. https://clinicaltrials.gov/study/NCT02338960, read 2026-09-05.
- A second completed phase 3 record registered in premenopausal women. https://clinicaltrials.gov/study/NCT02333071, read 2026-09-05.
- A completed phase 2 record registered in premenopausal women. https://clinicaltrials.gov/study/NCT01382719, read 2026-09-05.
- A completed phase 2 record registered in women. https://clinicaltrials.gov/study/NCT00425256, read 2026-09-05.
- An active, not recruiting phase 2 study of the compound given together with a second agent for the treatment of obesity. https://clinicaltrials.gov/study/NCT06565611, read 2026-09-05.
- A completed phase 2b open-label study in diabetic kidney disease. https://clinicaltrials.gov/study/NCT05709444, read 2026-09-05.
- A completed phase 4 record measuring the compound's concentration in breast milk. https://clinicaltrials.gov/study/NCT06867835, read 2026-09-05.
- A completed phase 1 record measuring the rate of nausea in healthy premenopausal female subjects. https://clinicaltrials.gov/study/NCT03973047, read 2026-09-05.
- A completed phase 4 record on the role of the melanocortin-4 receptor. https://clinicaltrials.gov/study/NCT04179734, read 2026-09-05.
Narrowest form: nine registrations, each anchored by its identifier and carrying no result.
What a registration reports
A registration reports that a study exists. It reports a status, a phase and a population, and it reports nothing about an outcome. A completed status reports that the work finished, not what it found. Why a row reads nothing runs on why a row reads nothing. The scope table is back on the scope table.
Narrowest form: a registration reports a study exists, and nothing else.
The supplier named in the lot record, answered plainly
What is Peptara Labs, and what does it publish?
Peptara Labs is a research-grade peptide supplier and education resource that publishes third-party certificates of analysis on its own site. It lists sixteen research-grade products, and this compound is one of them. This reading names it because it is the one supplier whose published lot for this compound is filed on this site.
Who tests the peptides Peptara Labs sells?
Titreon Analytical, described on the live page as a third-party laboratory whose quality system is aligned to ISO/IEC 17025:2017, not itself accredited. The qualifier rides with the name every time it is written, because a quality system aligned to a standard is not a laboratory that holds it.
Is Peptara Labs the source of an approved PT-141 product?
No. Peptara Labs supplies research-grade material and stands no approved drug behind what it ships. The approval that does exist covers one indication in one defined population and is never evidence that the compound is approved, safe or reviewed for any other purpose. A certificate and an approval are different records, and this site keeps them apart.
Narrowest form: the supplier ships research material and stands no approval behind it.
Scope and research use
The work here is reading. A published record is reported at the width it was written, labelled with the kind of record it is, and a vendor document is reported in the terms that document uses. Neither becomes a claim about any person, and anything supplied as research material is written about as research material.
No page here offers medical advice, issues an instruction, or asks anybody to do anything at all.
Narrowest form: reading only, no instruction, no claim about a person.